Broomfield, CO, May 01, 2016 --(PR.com
)-- MedAware Systems, Inc. announced today that Dr. Thomas Krummel is joining the Company’s Scientific Advisory Board.
Dr. Krummel is the Emile Holman Professor and immediate past Chair of the Department of Surgery at Stanford University School of Medicine, the Susan B. Ford Surgeon-in-Chief at Lucile Packard Children’s Hospital, and Co-Director of the Stanford Biodesign Program. He has extensive experience in medical research in the areas of fetal healing, cellular and biochemical mechanisms, and surgical innovation.
Dr. Krummel has also been a pioneer in the application of information technology to enhance the quality and safety of surgical education and reduce its staggering cost.
He is a member of a number of professional societies including the American College of Surgeons, the American Pediatric Surgical Association, the Society for Clinical Surgery, and the American Surgical Association. He serves as Chair of the Board of Directors of the Fogarty Institute for Innovation. In 1997 he was named a Director of the American Board of Surgery. He has served in leadership positions in many surgical organizations, and has been the recipient of numerous honors and awards. Dr. Krummel has lectured throughout the world and is author or co-author of over two hundred publications.
“We are honored and thrilled to have one of the true trailblazers in healthcare technology joining our Scientific Advisory Board”, said Peter Nichol, MD, PhD, Chair of MedAware Systems’ Scientific Advisory Board. He adds, “Through his leadership over the last 15 years as the Co-director of Stanford's Biodesign Program Dr. Krummel has helped incubate over 30 start-ups in the Med-Tech sector. His extensive experience, and unparalleled expertise in both the academic and business spheres of healthcare will be instrumental in the development of personalized, evidence-based treatment information for physicians and patients around the world.”
About MedAware Systems , Inc.
MedAware Systems is a leading company in evidence-based medical treatment efficacy information. The Company’s Personalized Clinical Decision Support system is a Scientific-Data-as-a-Service (SDaaS)™ that solves the problem of making the vast and chaotic body of human clinical trials research instantly available and indispensable in developing the patient plan of care. The Company aggregates, organizes, and standardizes data from all human clinical trials across various disease/condition areas to provide immediate and actionable information on medical treatments and outcomes.